← All trials
NCT00419263
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2007
- Primary completion
- Sep 1, 2007
- Completion date
- Sep 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 344
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- BioCrystLead sponsor
- Palm Beach Research CenterOverall official - principal investigator
- MEDEXOverall official - principal investigator
- Central Kentucky Research Assoc, IncOverall official - principal investigator
- Radiant ResearchOverall official - principal investigator
- The Brooklyn Hospital CenterOverall official - principal investigator
- University of Medicine and Dentistry of New JerseyOverall official - principal investigator
- George Washington UniversityOverall official - principal investigator
- Hillcrest Family PracticeOverall official - principal investigator
- Alpine Clinical Research CenterOverall official - principal investigator
- J. Lewis Research, IncOverall official - principal investigator
- Omega Medical ResearchOverall official - principal investigator
- University Clinical Research-Deland, LLCOverall official - principal investigator
- Hermitage MedicentresOverall official - principal investigator
- Manna ResearchOverall official - principal investigator
- Clinique medicale des CampusOverall official - principal investigator
- Paragon Clinical Research, Inc.Overall official - principal investigator
- Benchmark ResearchOverall official - principal investigator
- Castledowns MedicentreOverall official - principal investigator
- Wishard HospitalOverall official - principal investigator
- Gain Medical Research CentreOverall official - principal investigator
- Orange County Clinical TrialsOverall official - principal investigator
- Baylor UniversityOverall official - principal investigator
- Summa Emergency Associates Inc.Overall official - principal investigator
- Research Across AmericaOverall official - principal investigator
- Bozeman Urgent Care CenterOverall official - principal investigator
- New England Center for Clinical Research, IncOverall official - principal investigator
- Towngate Plaza Medical CenterOverall official - principal investigator
- Integrated Medical Research, PCOverall official - principal investigator
- Alliance Medical CenterOverall official - principal investigator
- Georgia Clinical ResearchOverall official - principal investigator
- Primary Physicians Research, IncOverall official - principal investigator
- Belvedere MedicentreOverall official - principal investigator
- Prairie ClinicalOverall official - principal investigator
- RJA MedicentresOverall official - principal investigator
- Balbir Chahal M.D. ,P.A.Overall official - principal investigator
- Jacksonville Center for Clinical ResearchOverall official - principal investigator
- Bascom Palmer Eye InstituteOverall official - principal investigator
- DM Clinical ResearchOverall official - principal investigator
- Sterling Research Group, LtdOverall official - principal investigator
- Omnispec Clinical Research Inc, Mirabel, CanadaOverall official - principal investigator
- University of CalgaryOverall official - principal investigator
- Pacific Sleep MedicineOverall official - principal investigator
- Clinical Research of South FloridaOverall official - principal investigator
- Kentucky Pediatric and Adult ResearchOverall official - principal investigator
- Washington University in St. LouisOverall official - principal investigator
- Advanced Clinical Research Inc.Overall official - principal investigator
- Q & T ResearchOverall official - principal investigator
- Wake Research AssociatesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.